A novel pathway to enhance adipocyte differentiation of 3T3-L1 cells by up-regulation of lipocalin-type prostaglandin D synthase mediated by liver X receptor-activated sterol regulatory element-binding protein-1c

scientific article published on 17 April 2007

A novel pathway to enhance adipocyte differentiation of 3T3-L1 cells by up-regulation of lipocalin-type prostaglandin D synthase mediated by liver X receptor-activated sterol regulatory element-binding protein-1c is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1074/JBC.M701141200
P698PubMed publication ID17439953

P50authorKo FujimoriQ39066313
P2093author name stringKosuke Aritake
Yoshihiro Urade
P2860cites workLiver X receptors are regulators of adipocyte gene expression but not differentiation: identification of apoD as a direct targetQ42832702
Depot-specific prostaglandin synthesis in human adipose tissue: a novel possible mechanism of adipogenesisQ44703208
Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humansQ44904582
Identification of gene polymorphism in lipocalin-type prostaglandin D synthase and its association with carotid atherosclerosis in Japanese hypertensive patientsQ45027226
Accelerated glucose intolerance, nephropathy, and atherosclerosis in prostaglandin D2 synthase knock-out miceQ46560412
Functional characterization of the human resistin promoter with adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element binding protein 1c and CCAAT enhancer binding protein-alphaQ47934135
Lipocalin-type prostaglandin D synthase is up-regulated in oligodendrocytes in lysosomal storage diseases and binds gangliosides.Q54615368
Role of LXRs in control of lipogenesisQ24290548
Obesity and insulin resistanceQ24607078
Lipocalin-type prostaglandin D synthase (beta-trace) is a newly recognized type of retinoid transporterQ28570239
Obesity-related overexpression of fatty-acid synthase gene in adipose tissue involves sterol regulatory element-binding protein transcription factorsQ28571146
Binding of biliverdin, bilirubin, and thyroid hormones to lipocalin-type prostaglandin D synthaseQ28572884
Global and societal implications of the diabetes epidemicQ29614551
Obesity and the regulation of energy balanceQ30080025
Lipocalin-type prostaglandin D synthase produces prostaglandin D2 involved in regulation of physiological sleep.Q30478455
Transcriptional activation of the human hematopoietic prostaglandin D synthase gene in megakaryoblastic cells. Roles of the oct-1 element in the 5'-flanking region and the AP-2 element in the untranslated exon 1.Q33918650
Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytesQ34121545
Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolismQ34284209
Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1.Q34451430
An established preadipose cell line and its differentiation in culture II. Factors affecting the adipose conversionQ34509691
Lipocalin-type prostaglandin D synthase/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid.Q35748577
Adipose tissue, inflammation, and cardiovascular diseaseQ36125401
ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiationQ36694542
Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor gamma expressionQ37277355
Sterol regulation of acetyl coenzyme A carboxylase: a mechanism for coordinate control of cellular lipidQ37728908
Dual DNA binding specificity of ADD1/SREBP1 controlled by a single amino acid in the basic helix-loop-helix domainQ38295909
Regulation of lipocalin-type prostaglandin D synthase gene expression by Hes-1 through E-box and interleukin-1 beta via two NF-kappa B elements in rat leptomeningeal cellsQ38359652
Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthaseQ40302517
Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1.Q40459310
Prostaglandin D2 synthase enzymes and PPARgamma are co-expressed in mouse 3T3-L1 adipocytes and human tissuesQ40667304
Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR.Q41130960
Expression of NADP+-dependent 15-hydroxyprostaglandin dehydrogenase mRNA in monkey ocular tissues and characterization of its recombinant enzymeQ42671170
On the role of liver X receptors in lipid accumulation in adipocytesQ42805825
Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandinsQ42806855
A Nuclear Receptor Atlas: 3T3-L1 adipogenesis.Q42811809
ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolismQ42813608
Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O.Q42818414
P433issue25
P407language of work or nameEnglishQ1860
P921main subjectadipocyteQ357519
P304page(s)18458-18466
P577publication date2007-04-17
P1433published inJournal of Biological ChemistryQ867727
P1476titleA novel pathway to enhance adipocyte differentiation of 3T3-L1 cells by up-regulation of lipocalin-type prostaglandin D synthase mediated by liver X receptor-activated sterol regulatory element-binding protein-1c
P478volume282

Reverse relations

cites work (P2860)
Q36135903Aldo-Keto Reductases 1B in Endocrinology and Metabolism
Q42581400Biochemical, functional, and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase
Q34452830Cyclooxygenase-2 deficiency attenuates adipose tissue differentiation and inflammation in mice
Q24630614Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis
Q34574376Expression of genes related to prostaglandin synthesis or signaling in human subcutaneous and omental adipose tissue: depot differences and modulation by adipogenesis
Q33781016Genome-wide analysis of glucocorticoid receptor binding regions in adipocytes reveal gene network involved in triglyceride homeostasis
Q35018078High-Quality Protein Crystal Growth of Mouse Lipocalin-Type Prostaglandin D Synthase in Microgravity
Q61796391L-PGDS-produced PGD in premature, but not in mature, adipocytes increases obesity and insulin resistance
Q28506812NMR solution structure of lipocalin-type prostaglandin D synthase: evidence for partial overlapping of catalytic pocket and retinoic acid-binding pocket within the central cavity
Q28586698Novel suppression mechanism operating in early phase of adipogenesis by positive feedback loop for enhancement of cyclooxygenase-2 expression through prostaglandin F2α receptor mediated activation of MEK/ERK-CREB cascade
Q45417013Platelet lysate suppresses the expression of lipocalin-type prostaglandin D2 synthase that positively controls adipogenic differentiation of human mesenchymal stromal cells
Q39449759Prevention of paraquat-induced apoptosis in human neuronal SH-SY5Y cells by lipocalin-type prostaglandin D synthase
Q43171502Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2 in vivo.
Q35129193Prostaglandin (PG) F2 alpha synthesis in human subcutaneous and omental adipose tissue: modulation by inflammatory cytokines and role of the human aldose reductase AKR1B1.
Q94686849Prostaglandin F2α agonist-induced suppression of 3T3-L1 cell adipogenesis affects spatial formation of extra-cellular matrix
Q28509544Prostaglandin reductase-3 negatively modulates adipogenesis through regulation of PPARγ activity
Q41873873Prostaglandins as PPARγ Modulators in Adipogenesis
Q36920540Retinol and retinyl esters: biochemistry and physiology
Q89612196Role of Mineralocorticoid Receptor in Adipogenesis and Obesity in Male Mice
Q42803031Stable expression of lipocalin-type prostaglandin D synthase in cultured preadipocytes impairs adipogenesis program independently of endogenous prostanoids
Q27643949Structural Basis of the Catalytic Mechanism Operating in Open-Closed Conformers of Lipocalin Type Prostaglandin D Synthase
Q39615733Suppression of adipocyte differentiation by aldo-keto reductase 1B3 acting as prostaglandin F2alpha synthase
Q34412709Synergistic suppression of early phase of adipogenesis by microsomal PGE synthase-1 (PTGES1)-produced PGE2 and aldo-keto reductase 1B3-produced PGF2α.
Q37173360Transcriptional regulation of adipocyte formation by the liver receptor homologue 1 (Lrh1)-Small hetero-dimerization partner (Shp) network

Search more.